Shares of Stellantis NV moved lower in Paris trading following a downgrade by HSBC, which shifted its recommendation from "hold" to "reduce" and trimmed its target price to €4 from €5.50. HSBC calculated that the new target implies roughly 21.8% downside relative to the July 2 closing price of €5.11.
The bank attributed its change in stance to weaker financial estimates and lower expected net cash for 2026. "We do not understand the logic of repeating past failures," HSBC analysts wrote, drawing attention to a mounting inventory position in the United States and persistent quality problems.
HSBC highlighted that Stellantis’ U.S. inventory reached 93 selling days in June 2026, an increase of about 120,000 units year-on-year and near the roughly 100-day peak the company experienced in 2024. To address that earlier inventory accumulation, Stellantis previously trimmed U.S. prices by 500-600 basis points and scaled back production by around 200,000 units, the broker noted. "If the inventory trend continues, then we see a repeat episode as being likely," HSBC said.
Quality and safety issues were central to the downgrade. Citing NHTSA data, HSBC said Stellantis issued 19 recalls covering 2.5 million vehicles year-to-date, with about 2 million of those affected vehicles requiring a physical inspection and possible mechanical repair. In full-year 2025, the company logged 53 recalls affecting 2.8 million units, including 1.8 million that involved non-software fixes.
In Europe, Stellantis recorded 47 recalls in the first half of 2026 versus 48 for all of 2025. By comparison, HSBC reported 45 recalls in aggregate across other major EU manufacturers over the same first-half period.
On market dynamics, HSBC commented that while a recovery is an attractive prospect, it is not assured. "A recovery is a tantalising prospect, but by no means a certainty," the broker said, noting mixed signs on U.S. market share reversal in June 2026.
The broker also raised questions about whether historically high margins reflect under-investment. HSBC suggested the group "may have started to see the reversal of US market share losses, although Jun-26 was mixed," and added that Stellantis may need to increase investment to secure a sustainable turnaround.
HSBC revised its valuation methodology and set a new sum-of-the-parts target of €4, down from the prior €5.50. The bank pointed out that the stock's 12-month forward consensus price-to-earnings ratio of 5.6 times compares with a global peer average of 8.2 times, representing a 32% discount versus a three-year average discount closer to 40%.
Reflecting weaker operating expectations, HSBC cut its 2026 adjusted operating income forecast by 59% to €1.52 billion, which implies a roughly 1% margin compared with the company's guidance of a "low single digit" margin. The broker also lowered its 2026 industrial free cash flow projection by 50%, to a negative €4.89 billion.
Contextual analysis
HSBC's downgrade centers on three linked concerns: inventory management in the U.S., ongoing recall activity and the potential need for higher investment to sustain margins. The broker’s revised forecasts and valuation reflect a more cautious view on Stellantis’ near-term operating performance and cash generation.